Blocking cGAS signaling for alcohol-related liver disease

DISEASE CATEGORY: Hepatic

INDICATION: Liver disease

Targeting the cGAS-IRF3 signaling pathway by inhibiting cGAS or the gap junction protein GJB1

Read the full 183 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE